新华制药(000756)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

000756 新华制药

已收盘 09-23 15:00:00

{"stockData":{"symbol":"000756","market":"SZ","secType":"STK","nameCN":"新华制药","latestPrice":15.8,"timestamp":1758611028000,"preClose":16.14,"halted":0,"volume":13053213,"delay":0,"changeRate":-0.0211,"floatShares":493000000,"shares":690000000,"eps":0.6211,"marketStatus":"已收盘","change":-0.34,"latestTime":"09-23 15:00:00","open":16.13,"high":16.14,"low":15.6,"amount":207000000,"amplitude":0.0335,"askPrice":15.8,"askSize":350,"bidPrice":15.79,"bidSize":41,"shortable":0,"etf":0,"ttmEps":0.6211,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1758677400000},"marketStatusCode":5,"adr":0,"adjPreClose":16.14,"symbolType":"stock","openAndCloseTimeList":[[1758591000000,1758598200000],[1758603600000,1758610800000]],"highLimit":17.75,"lowLimit":14.53,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":689776535,"isCdr":false,"pbRate":2.17,"roa":"--","peRate":25.438738,"roe":"4.33%","epsLYR":0.69,"committee":-0.479656,"marketValue":10898000000,"turnoverRate":0.0265,"status":1,"hkstockBrief":{"symbol":"00719","market":"HK","secType":"STK","nameCN":"山东新华制药股份","latestPrice":7.28,"timestamp":1758614197288,"preClose":7.4,"halted":0,"volume":2850000,"delay":0,"premium":"-57.84"},"floatMarketCap":7783000000},"requestUrl":"/m/hq/s/000756","defaultTab":"news","newsList":[{"id":"2567826103","title":"新华制药(000756.SZ)获枸橼酸西地那非口崩片药品注册证书","url":"https://stock-news.laohu8.com/highlight/detail?id=2567826103","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2567826103?lang=zh_cn&edition=full","pubTime":"2025-09-16 17:11","pubTimestamp":1758013905,"startTime":"0","endTime":"0","summary":"智通财经APP讯，新华制药(000756.SZ)公告， 公司收到国家药品监督管理局核准签发的枸橼酸西地那非口崩片《药品注册证书》。公告显示，枸橼酸西地那非口崩片用于治疗勃起功能障碍。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1345824.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0239","000756","BK0164"],"gpt_icon":0},{"id":"2567108041","title":"新华制药(000756.SZ)子公司获熊去氧胆酸胶囊药品注册证书","url":"https://stock-news.laohu8.com/highlight/detail?id=2567108041","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2567108041?lang=zh_cn&edition=full","pubTime":"2025-09-16 17:09","pubTimestamp":1758013745,"startTime":"0","endTime":"0","summary":"智通财经APP讯，新华制药(000756.SZ)公告，公司全资子公司山东淄博新达制药有限公司(简称“新达制药”)收到国家药品监督管理局核准签发的熊去氧胆酸胶囊《药品注册证书》。该药品用于治疗胆囊胆固醇结石(必须是X射线能穿透的结石，同时胆囊收缩功能须正常);胆汁淤积性肝病(如：原发性胆汁性肝硬化);胆汁反流性胃炎。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1345820.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"新华制药(000756.SZ)子公司获熊去氧胆酸胶囊药品注册证书","news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["000756","BK0239","BK0164"],"gpt_icon":0},{"id":"1129844562","title":"新华制药熊去氧胆酸胶囊获得国家药监局药品注册证书","url":"https://stock-news.laohu8.com/highlight/detail?id=1129844562","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1129844562?lang=zh_cn&edition=full","pubTime":"2025-09-16 16:48","pubTimestamp":1758012494,"startTime":"0","endTime":"0","summary":"新华制药熊去氧胆酸胶囊获得国家药监局药品注册证书。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0164","000756","BK0239"],"gpt_icon":0},{"id":"2565090145","title":"新华制药：在研创新药和仿制药聚焦12大方向","url":"https://stock-news.laohu8.com/highlight/detail?id=2565090145","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2565090145?lang=zh_cn&edition=full","pubTime":"2025-09-08 16:06","pubTimestamp":1757318767,"startTime":"0","endTime":"0","summary":"证券之星消息，新华制药(000756)09月08日在投资者关系平台上答复投资者关心的问题。投资者提问：尊敬的董秘，你好。贵公司在治疗心脑血管的疾病上有什么前沿科技项目，在创新药品及医疗领域有什么前沿性的开发，谢谢。新华制药回复：您好！公司在研的重点创新药和仿制药聚焦心脑血管类、解热镇痛类、消化系统类、抗代谢类、神经系统等12大方向。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025090800019111.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0164","BK0239","BK1161","06978","BK1574","000756","159992"],"gpt_icon":0},{"id":"2565229556","title":"新华制药最新公告：副总经理郑忠辉因个人原因辞职","url":"https://stock-news.laohu8.com/highlight/detail?id=2565229556","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2565229556?lang=zh_cn&edition=full","pubTime":"2025-09-05 17:34","pubTimestamp":1757064883,"startTime":"0","endTime":"0","summary":"新华制药(000756.SZ)公告称，郑忠辉因个人原因申请辞去公司副总经理职务，辞职后不在公司担任高管职务。截至目前，郑忠辉持有公司A股股份39.76万股。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025090500029299.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000756","BK0164","BK0239"],"gpt_icon":0},{"id":"2562777315","title":"股市必读：新华制药中报 - 第二季度单季净利润同比下降9.60%","url":"https://stock-news.laohu8.com/highlight/detail?id=2562777315","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2562777315?lang=zh_cn&edition=full","pubTime":"2025-08-28 05:36","pubTimestamp":1756330581,"startTime":"0","endTime":"0","summary":"业绩披露要点: 新华制药2025年中报显示，公司主营收入46.39亿元，同比下降1.98%；归母净利润2.24亿元，同比下降15.69%。股本股东变化股东户数变动近日新华制药披露，截至2025年6月30日公司股东户数为7.65万户，较2月28日减少1942.0户，减幅为2.48%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025082800004915.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000756"],"gpt_icon":0},{"id":"2562331587","title":"新华制药(000756.SZ)：上半年净利润2.24亿元 同比下降15.69%","url":"https://stock-news.laohu8.com/highlight/detail?id=2562331587","media":"格隆汇","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2562331587?lang=zh_cn&edition=full","pubTime":"2025-08-26 19:38","pubTimestamp":1756208322,"startTime":"0","endTime":"0","summary":"格隆汇8月26日丨新华制药(000756.SZ)公布2025年半年度报告，上半年公司实现营业收入46.39亿元，同比下降1.98%；归属于上市公司股东的净利润2.24亿元，同比下降15.69%；归属于上市公司股东的扣除非经常性损益的净利润2.11亿元，同比下降15.44%；基本每股收益0.32元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/08/26193852710426.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["000756"],"gpt_icon":0},{"id":"1158817224","title":"新华制药米诺地尔搽剂获国家药监局颁发药品注册证","url":"https://stock-news.laohu8.com/highlight/detail?id=1158817224","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1158817224?lang=zh_cn&edition=full","pubTime":"2025-08-26 17:26","pubTimestamp":1756200406,"startTime":"0","endTime":"0","summary":"新华制药米诺地尔搽剂获国家药监局颁发药品注册证","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0239","000756","BK0164"],"gpt_icon":0},{"id":"2560121977","title":"新华制药：全球重要的解热镇痛药生产和出口基地","url":"https://stock-news.laohu8.com/highlight/detail?id=2560121977","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2560121977?lang=zh_cn&edition=full","pubTime":"2025-08-18 16:12","pubTimestamp":1755504731,"startTime":"0","endTime":"0","summary":"证券之星消息，新华制药(000756)08月18日在投资者关系平台上答复投资者关心的问题。投资者提问：请问公司产品是否有减肥方面的业务？新华制药回复：您好！新华制药是全球重要的解热镇痛药生产和出口基地，公司产品名录请参见公司官网www.xhzy.com。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025081800020781.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0164","BK0239","000756"],"gpt_icon":0},{"id":"2557369761","title":"新华制药(000756.SZ)子公司获非那雄胺片药品注册证书","url":"https://stock-news.laohu8.com/highlight/detail?id=2557369761","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557369761?lang=zh_cn&edition=full","pubTime":"2025-08-05 16:56","pubTimestamp":1754384209,"startTime":"0","endTime":"0","summary":"智通财经APP讯，新华制药(000756.SZ)公告，公司全资子公司山东淄博新达制药有限公司(简称“新达制药”)收到国家药品监督管理局核准签发的非那雄胺片《药品注册证书》。非那雄胺片适用于治疗和控制良性前列腺增生(BPH)以及预防泌尿系统事件：降低发生急性尿潴留的危险性;降低需进行经尿道切除前列腺(TURP)和前列腺切除术的危险性。非那雄胺片可使肥大的前列腺缩小，改善尿流及改善前列腺增生有关的症状。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1325872.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"新华制药(000756.SZ)子公司获非那雄胺片药品注册证书","news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["000756","BK0239","BK0164"],"gpt_icon":0},{"id":"2557369295","title":"新华制药：子公司新达制药获得非那雄胺片药品注册证书","url":"https://stock-news.laohu8.com/highlight/detail?id=2557369295","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557369295?lang=zh_cn&edition=full","pubTime":"2025-08-05 16:51","pubTimestamp":1754383899,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["000756","BK1574","UCmain","BK0164","CNHmain","BK0239","BK1191","CYB","BPH","MUCmain","01477","MCNHmain"],"gpt_icon":0},{"id":"2555003787","title":"新华制药：在研创新药OAB14进入Ⅱ期临床","url":"https://stock-news.laohu8.com/highlight/detail?id=2555003787","media":"金融界","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555003787?lang=zh_cn&edition=full","pubTime":"2025-07-29 08:39","pubTimestamp":1753749560,"startTime":"0","endTime":"0","summary":"金融界7月29日消息，有投资者在互动平台向新华制药提问：请问公司在创新药领域是否有布局研发？具体品种。项目有哪些？目前分别进展到了哪一阶段？请详细说明，非常感谢。公司回答表示：您好！公司围绕心脑血管类、解热镇痛类、消化系统类、抗代谢类、神经系统等12个方向开展研发工作，包括创新药物和仿制药。进入研发管线的药物有100多个。在创新药领域已构建多个大研发平台（如新型给药系统、小分子创新等），在研产品包括进入Ⅱ期临床的OAB14（用于阿尔茨海默病治疗）等多个创新药物进展顺利。\n\n\r\n            责任编辑：栎树","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/07/29083952038063.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["159992","06978","BK1574","000756","BK0164","BK0239","BK1161"],"gpt_icon":0},{"id":"2553702362","title":"新华制药：公司是全球解热镇痛类药物主要生产商之一","url":"https://stock-news.laohu8.com/highlight/detail?id=2553702362","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2553702362?lang=zh_cn&edition=full","pubTime":"2025-07-24 16:42","pubTimestamp":1753346528,"startTime":"0","endTime":"0","summary":"证券之星消息，新华制药(000756)07月24日在投资者关系平台上答复投资者关心的问题。投资者提问：尊敬的董秘您好！    请问针对广东省佛山市大量基孔肯雅热病患者，随着病情外溢扩散，公司有没有产生的药品可以治疗该患者？新华制药回复：您好！公司是全球解热镇痛类药物主要生产商之一，公司产品名录请参见公司官网。谢谢！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025072400025678.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000756","BK0239","BK0164"],"gpt_icon":0},{"id":"2551923319","title":"新华制药新提交4件商标注册申请","url":"https://stock-news.laohu8.com/highlight/detail?id=2551923319","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551923319?lang=zh_cn&edition=full","pubTime":"2025-07-14 04:59","pubTimestamp":1752440361,"startTime":"0","endTime":"0","summary":"证券之星消息，根据天眼查APP数据显示，近日山东新华制药股份有限公司新提交4件商标注册申请。商标申请详情如下：今年以来山东新华制药股份有限公司新申请注册商标15件，截止目前公司共持有注册商标753件，另有79件商标尚在注册申请中。通过天眼查大数据分析，山东新华制药股份有限公司共对外投资了19家企业，参与招投标项目13783次；财产线索方面有商标信息556条，专利信息521条；此外企业还拥有行政许可855个。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025071400001148.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0164","000756"],"gpt_icon":0},{"id":"2550987491","title":"新华制药：金泽百处于销售前准备阶段","url":"https://stock-news.laohu8.com/highlight/detail?id=2550987491","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550987491?lang=zh_cn&edition=full","pubTime":"2025-07-11 16:32","pubTimestamp":1752222734,"startTime":"0","endTime":"0","summary":"证券之星消息，新华制药(000756)07月11日在投资者关系平台上答复投资者关心的问题。投资者提问：请问公司获批上市的二十碳五烯酸乙酯开始销售了吗？商品名叫什么？新华制药回复：您好！从药品批准上市到实现销售，通常需要几个月时间进行准备。公司二十碳五烯酸乙脂软胶囊商品名叫“金泽百”，处于销售前准备阶段。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025071100026076.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0164","000756"],"gpt_icon":0},{"id":"2550019856","title":"异动快报：新华制药（000756）7月11日11点4分触及涨停板","url":"https://stock-news.laohu8.com/highlight/detail?id=2550019856","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550019856?lang=zh_cn&edition=full","pubTime":"2025-07-11 11:05","pubTimestamp":1752203120,"startTime":"0","endTime":"0","summary":"证券之星7月11日盘中消息，11点4分新华制药触及涨停板。目前价格17.67，上涨10.02%。其所属行业化学制药目前上涨。领涨股为常山药业。该股为创新药，阿尔茨海默病，化学原料药概念热股，当日创新药概念上涨1.42%，阿尔茨海默病概念上涨1.12%，化学原料药概念上涨1.02%。7月10日的资金流向数据方面，主力资金净流入1163.33万元，占总成交额3.54%，游资资金净流出644.94万元，占总成交额1.96%，散户资金净流出518.39万元，占总成交额1.58%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"2aef863af026efdbcf49dc72815bfda3","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025071100013021.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0164","000756","BK0239"],"gpt_icon":0},{"id":"2550665948","title":"新华制药新提交“率活力”等2件商标注册申请","url":"https://stock-news.laohu8.com/highlight/detail?id=2550665948","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550665948?lang=zh_cn&edition=full","pubTime":"2025-07-10 05:07","pubTimestamp":1752095278,"startTime":"0","endTime":"0","summary":"证券之星消息，根据天眼查APP数据显示，近日山东新华制药股份有限公司新提交“率活力”等2件商标注册申请。商标申请详情如下：今年以来山东新华制药股份有限公司新申请注册商标11件，截止目前公司共持有注册商标753件，另有75件商标尚在注册申请中。通过天眼查大数据分析，山东新华制药股份有限公司共对外投资了19家企业，参与招投标项目13776次；财产线索方面有商标信息556条，专利信息520条；此外企业还拥有行政许可855个。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025071000003393.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0164","BK0239","000756"],"gpt_icon":0},{"id":"2547060069","title":"新华制药(000756.SZ)获得精氨酸布洛芬化学原料药上市申请批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2547060069","media":"智通财经网","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2547060069?lang=zh_cn&edition=full","pubTime":"2025-06-30 17:12","pubTimestamp":1751274769,"startTime":"0","endTime":"0","summary":"智通财经APP讯，新华制药(000756.SZ)发布公告，近日，公司收到国家药品监督管理局核准签发的精氨酸布洛芬《化学原料药上市申请批准通知书》。精氨酸布洛芬主要用于牙痛、痛经、因创伤引起的疼痛(例如：运动性损伤)、关节和韧带痛、背痛、头痛、神经痛以及流感引起的发热。更多港股重磅资讯，下载智通财经app更多港股及海外理财资讯，请点击www.zhitongcaijing.com（搜索“智通财经”）；欲加入智通港股投资群，请加智通客服微信(ztcjkf)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1311793.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"新华制药(000756.SZ)获得精氨酸布洛芬化学原料药上市申请批准","news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["000756","BK0164","BK0239"],"gpt_icon":0},{"id":"2547061838","title":"【新华制药：盐酸伊伐布雷定片获药品注册证书】新华制药公告，全资子公司山东淄博新达制药有限公司收到国家药品监督管理局核准签发的盐酸伊伐布雷定片《药品注册证书》。该药品适用于窦性心律且心率≥75次/分钟、伴有心脏收缩功能障碍的NYHAⅡ~Ⅳ级慢性心力衰竭患者，与标准治疗包括β-受体阻滞剂联合用药，或者用于禁忌或不能耐受β-受体阻滞剂治疗时。2024年中国城市公立医疗机构盐酸伊伐布雷定片销售额约3.5亿元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2547061838","media":"金融界","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2547061838?lang=zh_cn&edition=full","pubTime":"2025-06-30 17:10","pubTimestamp":1751274638,"startTime":"0","endTime":"0","summary":"新华制药公告，全资子公司山东淄博新达制药有限公司收到国家药品监督管理局核准签发的盐酸伊伐布雷定片《药品注册证书》。该药品适用于窦性心律且心率≥75次/分钟、伴有心脏收缩功能障碍的NYHAⅡ~Ⅳ级慢性心力衰竭患者，与标准治疗包括β-受体阻滞剂联合用药，或者用于禁忌或不能耐受β-受体阻滞剂治疗时。2024年中国城市公立医疗机构盐酸伊伐布雷定片销售额约3.5亿元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/06/30171051387818.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["000756","BK0164","BK1574","BK1191","BK0239","01477"],"gpt_icon":0},{"id":"2544915684","title":"新华制药(000756.SZ)：OAB-14干混悬剂完成Ⅱ期临床中国首例患者入组","url":"https://stock-news.laohu8.com/highlight/detail?id=2544915684","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2544915684?lang=zh_cn&edition=full","pubTime":"2025-06-19 16:17","pubTimestamp":1750321031,"startTime":"0","endTime":"0","summary":"智通财经APP讯，新华制药(000756.SZ)公告，公司治疗轻至中度阿尔兹海默病的OAB-14干混悬剂完成Ⅱ期临床中国首例患者入组。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1307207.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"新华制药(000756.SZ)：OAB-14干混悬剂完成Ⅱ期临床中国首例患者入组","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["000756","BK0164","BK0239"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1758623965408,"stockEarnings":[{"period":"1week","weight":-0.0444},{"period":"1month","weight":-0.0171},{"period":"3month","weight":0.0888},{"period":"6month","weight":0.0845},{"period":"1year","weight":0.165},{"period":"ytd","weight":0.0424}],"compareEarnings":[{"period":"1week","weight":-0.0083},{"period":"1month","weight":0.0007},{"period":"3month","weight":0.1193},{"period":"6month","weight":0.1365},{"period":"1year","weight":0.3989},{"period":"ytd","weight":0.1423}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"山东新华制药股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"76468人(较上一季度增加Infinity%)","perCapita":"6442股","listingDate":"1997-08-06","address":"山东省淄博市张店区高新技术产业开发区化工区","registeredCapital":"68977万元","survey":"　　山东新华制药股份有限公司的主营业务是开发、制造和销售化学原料药、制剂及化工产品。公司的主要产品是“新华牌”解热镇痛类药物、心脑血管类、抗感染类及中枢神经类等药物。1个项目获山东省2024年度科技进步二等奖。","listedPrice":3.45},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.3","shortVersion":"4.35.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"新华制药(000756)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供新华制药(000756)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"新华制药,000756,新华制药股票,新华制药股票老虎,新华制药股票老虎国际,新华制药行情,新华制药股票行情,新华制药股价,新华制药股市,新华制药股票价格,新华制药股票交易,新华制药股票购买,新华制药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"新华制药(000756)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供新华制药(000756)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}